Skip to main content
Midas Edge

13-F holdings, Q2 2026

Patient Capital Management, LLC

A 13-F is the report large US investment managers file with the SEC each quarter, listing the stocks they held at quarter end.

Reported value
$3B
Positions
39
Filed
Data as of

These holdings are as of , 130 days ago.

13-Fs for Q3 2026 are due by .

Read filingRead the filing on SEC.gov

See this manager's Holder IQ and how the book overlaps yours

Free to start, with no card. Holder IQ scores a manager's past record. It describes the past and is not a recommendation to buy or sell anything. Sign up and you can follow this manager: one notice for each new 13-F, naming what changed and which of those positions you hold or watch.

Start freeAlready have an account? Sign in

Top holdings

  1. RPRX$201.8M
    3,598,808 shares6.7% of the book
  2. C$196.4M
    1,403,477 shares6.5% of the book
  3. GOOGL$187.9M
    525,750 shares6.2% of the book
  4. UNH$182M
    437,773 shares6% of the book
  5. AMZN$162.3M
    681,047 shares5.4% of the book
  6. NVDA$142M
    709,587 shares4.7% of the book
  7. CVS$127.8M
    1,235,505 shares4.2% of the book
  8. NCLH$127.3M
    6,029,642 shares4.2% of the book
  9. QXO$123.3M
    7,136,669 shares4.1% of the book
  10. ET$116.3M
    6,080,678 shares3.9% of the book

What changed this quarter

2 new positions and 1 sold out, against Q1 2026. A buy or sell is the change in shares at the Q2 2026 price, with Q1 2026 shares adjusted for stock splits.

Largest buys

  • GPN

    GLOBAL PMTS INC

    +$68.4M

    New

  • FBTC

    FIDELITY WISE ORIGIN BITCOIN

    +$44.1M

    +244.1% shares

  • CHYM

    CHIME FINL INC

    +$24.6M

    +41.7% shares

  • ADBE

    ADOBE INC

    +$13.1M

    +21.5% shares

  • PGEN

    PRECIGEN INC

    +$7M

    +6.8% shares

Largest sells

  • NE

    NOBLE CORP PLC

    −$46.5M

    -92.6% shares

  • IBIT

    ISHARES BITCOIN TRUST ETF

    −$42.3M

    Sold out, was 1.6% of the book

  • ILMN

    ILLUMINA INC

    −$35.1M

    -36.6% shares

  • BIIB

    BIOGEN INC

    −$20.8M

    -25.3% shares

  • UBS

    UBS GROUP AG

    −$14.3M

    -23.2% shares

What was sold out, by size

  • 1 real positions, 0.25% of the book or more

All of this comes from the filer's public SEC filings. A 13-F shows long positions in US-listed securities at quarter end and can leave out short positions, cash and non-US holdings, so it is not the whole portfolio. This is filing data, not investment advice.